Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
Status:
Terminated
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether molecular profile-directed therapy
(otherwise known as personalized treatment) can improve the effectiveness of standard
chemotherapy combinations for patients with esophagogastric adenocarcinoma. A series of tests
will be performed on a sample of tumor; based on the results of these tests, a patient will
be assigned to a chemotherapy treatment.